Table: OncoTherapy Science -Q1 group results

OncoTherapy Science

04/08/2017 09:00

Aug 4 (Reuters)-  
             OncoTherapy Science Inc  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 3 months ended      3 months ended       Year to  
                Jun 30, 2017        Jun 30, 2016     Mar 31, 2018  
                   LATEST             YEAR-AGO          LATEST     
                   RESULTS             RESULTS         FORECAST    
  Sales            200 mln              0 mln                      
                                     (-99.8 pct)                   
  Operating     loss 593 mln        loss 783 mln                   
  Recurring     loss 590 mln        loss 770 mln                   
  Net           loss 568 mln        loss 764 mln                   
  EPS           loss 3.86 yen       loss 5.20 yen                  
  Ann Div                                NIL              NIL      
  -Q2 div 
  -Q4 div                                NIL              NIL      
   
  NOTE - OncoTherapy Science Inc.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4564.T  
  ((Tokyo Headline News Desk +813 6441 1812))